Popular flu medication's neurologic side effects in children studied

September 9, 2011
Figure 1: Positron emission tomography (PET) reveals markedly greater uptake of radioactively labeled verapamil in infant rhesus macaque brains (left) relative to adults (right). The top images represent individual scans, and the bottom images represent 3D reconstructions from those scans. Credit: 2011 Tadayuki Takashima & Kayo Onoe

Oseltamivir is the weapon of choice for preventing influenza infection from taking hold, but like any other drug, it also has the potential for adverse effects. Children in particular are susceptible to neurological symptoms, including delirium and an increased tendency for self-injury.

In partnership with University of Tokyo researcher Yuichi Sugiyama, a team led by Hirotaka Onoe at the RIKEN Center for Molecular Imaging Science, Kobe, recently discovered how age might influence the effects of oseltamivir1. “We speculated that changes in drug transporter function may influence the penetration of oseltamivir and its effects in the ,” says Onoe.

The capillaries that oxygenate the brain are tightly sealed to prevent potentially toxic compounds or pathogens in the blood from penetrating the central nervous system. Specialized transporter proteins that pump toxic compounds out of the brain bolster the effectiveness of this ‘blood–brain barrier’. 

Oseltamivir and verapamil, a drug for cardiac arrhythmia, are believed to be exported by the P-glycoprotein (P-gp) transporter protein. Onoe and colleagues therefore tracked the circulation of radioactively labeled drugs in infant, adolescent and adult rhesus macaques to monitor whether or not P-gp function changes as monkeys age.

Strikingly, both drugs achieved considerably greater penetration into the brain in younger animals. For example, the maximum concentration of oseltamivir within the brain was 3.7-fold higher in infants than adults, and 2.7-fold higher in adolescents relative to their elder counterparts. 

Similar results were observed with verapamil (Fig. 1). Some of this disparity could be accounted for by increased overall drug levels in the bodies of younger animals, possibly due to less efficient metabolic processing. However, even when this effect was accounted for, the researchers found clear evidence that older animals purge verapamil from the brain faster than infants and adolescents.

These results are in keeping with previous studies in rodents, which have indicated that P-gp levels increase as animals get older. “The most interesting finding from this study is the significant difference in P-glycoprotein function observed among nonhuman primates of different ages,” says Onoe.

The extent to which the physiology of drug clearance in nonhuman primates mirrors that of humans remains the subject of debate. Nevertheless, these findings suggest a mechanism by which and other drugs could provoke adverse neurological effects in younger patients. Onoe and colleagues hope to further pursue their hypothesis. “We’d like to try clinical studies to assess the evidence found in this study, and understand the ontogeny of drug transporter function in humans,” he says.

Explore further: Genetic difference predicts antidepressant response

More information: Takashima, T., et al. Developmental changes in P-glycoprotein function in the blood–brain barrier of nonhuman primates: PET study with R-11C-verapamil and 11C-oseltamivir. Journal of Nuclear Medicine 52, 950–957 (2011).

Related Stories

Genetic difference predicts antidepressant response

January 23, 2008

Researchers have identified subtle genetic variations that predict the efficacy of two widely used antidepressant drugs. They found that certain variants in the gene for a protective transporter protein that pumps drugs and ...

Brain study may lead to improved epilepsy treatments

April 14, 2008

Using a rodent model of epilepsy, researchers found one of the body’s own neurotransmitters released during seizures, glutamate, turns on a signaling pathway in the brain that increases production of a protein that could ...

Research suggests mercury linked to dementia

November 16, 2010

New research by Northeastern University professor Richard Deth and academic colleagues in Germany suggests that long-term exposure to mercury may produce Alzheimer’s-like symptoms in people.

Recommended for you

New method creates endless supply of kidney precursor cells

August 25, 2016

Salk Institute scientists have discovered the holy grail of endless youthfulness—at least when it comes to one type of human kidney precursor cell. Previous attempts to maintain cultures of the so-called nephron progenitor ...

Strict diet combats rare progeria aging disorders

August 25, 2016

Mice with a severe aging disease live three times longer if they eat thirty percent less. Moreover, they age much healthier than mice that eat as much as they want. These are findings of a joint study being published today ...

New avenue for understanding cause of common diseases

August 25, 2016

A ground-breaking Auckland study could lead to discoveries about many common diseases such as diabetes, cancer and dementia. The new finding could also illuminate the broader role of the enigmatic mitochondria in human development.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.